Senior insider sale
Chief Executive Officer at NEWAMSTERDAM PHARMA CO N.V. — senior position signals high conviction
$26.80M
761.85K shares
What this filing means
DAVIDSON MICHAEL H. plans to sell 761.85K shares of NEWAMSTERDAM PHARMA CO N.V. valued at approximately $26.80M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001968582-26-000187
DirectorOfficer· Chief Executive Officer
Since Mar 2026
761.85K
Shares to sell
$26.80M
Approx. market value
443.71K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Option Exercise
Cash
3/2/2026
443.71KTotal acquired443.71K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/2/2026 | Option Exercise Cash | 443.71K | — |
| Total | 443.71K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
183.33K
Market value
$6.26M
2/26/2026
—Completed
Units to sell
58.25K
Market value
$2.06M
2/25/2026
—Completed
Units to sell
64.71K
Market value
$2.34M
2/24/2026
—Completed
Units to sell
11.85K
Market value
$410.9K
1/7/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
443.71K
Market value
$15.73M
3/2/2026
Total
Units
761.85K
Value
$26.80M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/26/2026 | 183.33K | $6.26M | — | Completed |
2/25/2026 | 58.25K | $2.06M | — | Completed |
2/24/2026 | 64.71K | $2.34M | — | Completed |
1/7/2026 | 11.85K | $410.9K | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 443.71K | $15.73M | Nasdaq | Planned |
| Total | 761.85K | $26.80M | ||